Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
Biotechnology Progress · 2023-11 · 39 (6)
DOI: 10.1002/btpr.3374 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Progress, online erschienen am 16.07.2023. Verfasst von Faezeh Ebrahimi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory, Student Research Committee, Gonabad University of Medical Sciences, Gonabad, Iran. Hauptthemen laut MEDLINE: Regenerative Medicine, Mesenchymal Stem Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs‐based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Laboratory, Student Research Committee, Gonabad University of Medical Sciences, Gonabad, Iran.
- Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
- Department of Biochemistry, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
- Medical Technical College, Al-Farahidi University, Baghdad, Iraq.
- Department of Anesthesia Techniques, AlNoor University College, Nineveh, Iraq.
- Department of Dentistry, Al-Zahrawi University College, Karbala, Iraq.
ORCID-Profile: Majid Zamani
Zitieren
APA
Ebrahimi, F., Pirouzmand, F., Cosme Pecho, R. D., Alwan, M., Yassen Mohamed, M., Ali, M. S., Hormozi, A., Hasanzadeh, S., Daei, N., Hajimortezayi, Z., & Zamani, M. (2023). Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science. Biotechnology Progress, 39(6). https://doi.org/10.1002/btpr.3374
Vancouver
Ebrahimi F, Pirouzmand F, Cosme Pecho RD, Alwan M, Yassen Mohamed M, Ali MS, et al. Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science. Biotechnology Progress. 2023;39(6). doi:10.1002/btpr.3374
BibTeX
@article{Ebrahimi2023,
author = {Ebrahimi, Faezeh and Pirouzmand, Farzaneh and Cosme Pecho, Renzon Daniel and Alwan, Mariam and Yassen Mohamed, Mohammed and Ali, Mohammed Shnain and Hormozi, Arezoo and Hasanzadeh, Sajedeh and Daei, Narges and Hajimortezayi, Zahra and Zamani, Majid},
title = {Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science},
journal = {Biotechnology Progress},
year = {2023},
volume = {39},
number = {6},
doi = {10.1002/btpr.3374}
}
EUVIMED